MBC BioLabs
Overview
MBC BioLabs is a biotech incubator that provides lab space and operational support for early-stage biotech companies . The company offers access to equipment and a community to facilitate the development and launch of biotech innovations, primarily serving the biotech sector .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DeepSeq.AI | May 2025 | Grant | Co-investor |
| Aptah Bio | Aug 2023 | Series A | Co-investor |
| Deciduous Therapeutics | Oct 2021 | Grant | Co-investor |
| Asher Biotherapeutics | Mar 2021 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is MBC BioLabs based?
MBC BioLabs is headquartered in San Francisco, California, United States.
When was MBC BioLabs founded?
MBC BioLabs was founded in 2013.
How many portfolio companies does MBC BioLabs have?
MBC BioLabs has 7 portfolio companies in Caplight's dataset.
What are some companies in MBC BioLabs's portfolio?
Recent investments visible on Caplight include DeepSeq.AI, Aptah Bio, Deciduous Therapeutics, Aptah Bio, Asher Biotherapeutics.
What was MBC BioLabs's most recent investment?
MBC BioLabs's most recent investment on Caplight was in DeepSeq.AI in 2025.
What sectors does MBC BioLabs focus on?
MBC BioLabs focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does MBC BioLabs focus on?
MBC BioLabs typically invests at the Early stage.